Immunogenicity and safety of inactivated SARS-CoV-2 vaccine in haemodialysis patients: a prospective cohort study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Metalia,Puspitasari

第一单位： Department of Internal Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta, Indonesia. metaliapuspitasari@ugm.ac.id.

作者： Metalia,Puspitasari ^[1] ; Prenali D,Sattwika ^[2] ; Dzerlina S,Rahari ^[3] ; Wynne,Wijaya ^[4] ; Auliana R P,Hidayat ^[3] ; Nyoman,Kertia ^[2] ; Bambang,Purwanto ^[2] ; Jarir At,Thobari ^[2]

作者单位： Department of Internal Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta, Indonesia. metaliapuspitasari@ugm.ac.id. ^[1] Department of Internal Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta, Indonesia. ^[2] Clinical Epidemiology and Biostatistics Unit, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta, Indonesia. ^[3] Cardiovascular Clinical Research Facility, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. ^[4] Department of Internal Medicine, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia. ^[5] Department of Pharmacology and Therapy, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia. ^[6]